2013年度の論文リスト

各年度の論文リスト

• 2014年度の論文リスト
• 2013年度の論文リスト
• 2012年度の論文リスト

※ボタンをクリックすると年度ごとに一覧を参照できます

2013年度の論文リスト

Detection of estrogen-independent growth-stimulating activity in breast cancer tissues: implication for tumor aggressiveness.
Yamaguchi Y, Seino Y, Takei H, Kurosumi M, Hayashi S.
Cancer Microenvironment. 2013 in press.

Cytokine profiles, signalling pathways and effects of fluticasone propionate in respiratory syncytial virus-infected human foetal lung fibroblasts.
Seki E, Yoshizumi M, Tanaka R, Ryo A, Ishioka T, Tsukagoshi H, Kozawa K, Okayama Y,Okabe-Kado J, Goya T, Kimura H.
Cell Biol Int. 2013 in press

ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.
Ikuta T, Kobayashi Y, Kitazawa M, Shiizaki K, Itano N, Noda T, Pettersson S, Poellinger L, Fujii-Kuriyama Y, Taniguchi S, Kawajiri K.
Carcinogenesis. 2013 34: 1620-1627.

Tumor promoters: from chemicals to inflammatory proteins.
Fujiki H, Sueoka E, Suganuma M.
J Cancer Res Clin Oncol. 2013 139:1603-1614.

Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S.
Breast Cancer Res Treat. 2013 139:731-40.

RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.
Honda S, Miyagi H, Suzuki H, Minato M, Haruta M, Kaneko Y, Hatanaka KC, Hiyama E, Kamijo T, Okada T, Taketomi A.
Pediatr Surg Int. 2013 29: 1147-1152.

Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
Takada M, Higuchi T, Tozuka K, Takei H, Haruta M, Watanabe J, Kasai F, Inoue K, Kurosumi M, Miyazaki M, Sato-Otsubo A, Ogawa S, Kaneko Y.
BMC Cancer. 2013 13: 241.

Meiosis error and subsequent genetic and epigenetic alterations invoke the malignant transformation of germ cell tumor.
Ichikawa M, Arai Y, Haruta M, Furukawa S, Ariga T, Kajii T, Kaneko Y.
Genes Chromosomes Cancer. 2013 52: 274-286.

The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element.
Fukunaga, J., Nomura, Y., Tanaka Y., Amano, R., Tanaka, T., Nakamura, Y., Kawai, G., Sakamoto, T., Kozu, T.
RNA. 2013 19: 927-936.

Solution structure of a DNA mimicking motif of an RNA aptamer against transcription factor AML1 Runt domain.
Nomura, Y., Tanaka, Y., Fukunaga, J., Fujiwara, K., Chiba, M., Iibuchi, H., Tanaka, T., Nakamura, Y., Kawai, G., Kozu T., Sakamoto, T.
J. Biochem. 2013 154: 513-519.

Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cells.
Kasukabe T, Okabe-Kado J, Haranosono Y, Kato N, Honma Y.
Int J Oncol. 2013 42: 767-75.

DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
Ooki A, Yamashita K, Yamaguchi K, Mondal A, Nishimiya H, Watanabe M.
Mol Cancer Res. 2013 11: 1362-1374.